Skip to content

Echocardiography in Nursing Home

Implementation and Effectiveness of Screening Echocardiography Performed in Nursing Home: ECHOGER

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06445231
Acronym
ECHOGER
Enrollment
1050
Registered
2024-06-06
Start date
2024-10-02
Completion date
2030-01-01
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases, Heart Failure, Heart Valve Diseases

Keywords

Echocardiography, Nursing Home, Implementation, Heart Failure

Brief summary

The study seeks to explore the implementation characteristics (acceptability, appropriateness, feasibility, adoption, fidelity, penetration, implementation cost and sustainability) of systematic echocardiography in nursing homes and its impact on rates of heart failure flare-up and unscheduled hospitalization at 12 months among included nursing homes.

Detailed description

Open-label cluster randomized type 1 hybrid trial, with 2 parallel arms: nursing homes will be randomized in the interventional (echocardiography by sonographer) or non-interventional arms (usual care). In the interventional arm echocardiography will be proposed to all residents of the nursing home at baseline. Clinical management will be adapted to the result of echocardiography by the general practitioner, in accordance with the cardiologist. The main objective is to assess the impact at 12 months of the initial performance of a systematic simplified echocardiography on the rate of nursing home residents presenting with heart failure episode or cardiovascular pathology. The Primary endpoint is the number of nursing home residents presenting a heart failure episode or an unscheduled hospitalization for heart failure or other cardiovascular pathologies at 12 months. Thirty nursing homes and 1050 residents will be included overall

Interventions

DIAGNOSTIC_TESTImplementation of echocardiography in nursing homes

An ultrasound will be carried out in the EHPAD, the result of which will be interpreted by a cardiologist then sent to the establishment and the attending physician with instructions to follow.

Sponsors

Directorate of Health Care Supply
CollaboratorUNKNOWN
Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Masking description

Not relevant

Intervention model description

Nursing home randomization in 1:1 ratio between echocardiography and no-echocardiography

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

: Nursing homes residents with a life-expectancy estimated \> 1 year, and able to participate to the study, giving an oral consent

Exclusion criteria

: * no accessible to echocardiography * closed unit (severe Alzheimer disease…) * recent contagious disease such Covid (\<15 days) * no consent to participate * no social security number

Design outcomes

Primary

MeasureTime frameDescription
Count of resident presenting a heart failure decompensation12 monthsNumber of residents with heart failure flare (worsening of at least 1 NYHA class) or unplanned hospitalization for heart failure

Secondary

MeasureTime frameDescription
Presence of a clinically significative change in medical management and care in the month following ultrasound12 monthsA binary outcome will be constructed, based on the following algorithm: clinically significative change set to yes if a change in ongoing drug prescription is observed, and/or a cardiologist visit is planned, and/or a geriatrist visit is planned, and/or an hospitalization for clinical work-up is set, and/or a resume of the ultrasound is sent to the GP. Otherwise (all components set to absent), this outcome will be set to None.

Countries

France

Contacts

Primary ContactThierry LE TOURNEAU, PU-PH
thierry.letourneau@chu-nantes.fr33 2 40 16 54 98
Backup ContactAnne-Sophie BOUREAU, PH
annesophie.boureau@chu-nantes.fr33 2 40 16 85 35

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026